123 related articles for article (PubMed ID: 7745010)
1. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins GE; Granleese S; Hegele RG; Holden J; Anderson DW; Bondy GP
J Clin Endocrinol Metab; 1995 May; 80(5):1628-34. PubMed ID: 7745010
[TBL] [Abstract][Full Text] [Related]
2. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.
Berndt T; Craig TA; Bowe AE; Vassiliadis J; Reczek D; Finnegan R; Jan De Beur SM; Schiavi SC; Kumar R
J Clin Invest; 2003 Sep; 112(5):785-94. PubMed ID: 12952927
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma.
Stone E; Bernier V; Rabinovich S; From GL
Clin Invest Med; 1984; 7(3):179-85. PubMed ID: 6518684
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of tumor cell bioactivity in oncogenic osteomalacia.
Nelson AE; Namkung HJ; Patava J; Wilkinson MR; Chang AC; Reddel RR; Robinson BG; Mason RS
Mol Cell Endocrinol; 1996 Nov; 124(1-2):17-23. PubMed ID: 9027320
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of renal epithelial phosphate transport in tumor-induced osteomalacia and uremia.
Kumar R; Haugen JD; Wieben ED; Londowski JM; Cai Q
Proc Assoc Am Physicians; 1995 Oct; 107(3):296-305. PubMed ID: 8608414
[TBL] [Abstract][Full Text] [Related]
6. Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells.
Jonsson KB; Mannstadt M; Miyauchi A; Yang IM; Stein G; Ljunggren O ; Jüppner H
J Endocrinol; 2001 Jun; 169(3):613-20. PubMed ID: 11375132
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic osteomalacia from pterygopalatine fossa mass.
Savage CR; Zimmer LA
J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report.
David K; Revesz T; Kratimenos G; Krausz T; Crockard HA
J Neurosurg; 1996 Feb; 84(2):288-92. PubMed ID: 8592237
[TBL] [Abstract][Full Text] [Related]
9. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia.
Reis-Filho JS; Paiva ME; Lopes JM
Brain Pathol; 2004 Jan; 14(1):111-2, 115. PubMed ID: 14997944
[TBL] [Abstract][Full Text] [Related]
10. Tumorous phosphaturic osteomalacia. Report of a case associated with multiple hemangiomas of bone.
Daniels RA; Weisenfeld I
Am J Med; 1979 Jul; 67(1):155-9. PubMed ID: 223441
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia: is there a new phosphate regulating hormone?
Nelson AE; Robinson BG; Mason RS
Clin Endocrinol (Oxf); 1997 Dec; 47(6):635-42. PubMed ID: 9497867
[TBL] [Abstract][Full Text] [Related]
12. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
Tsujimura T; Sakaguchi K; Aozasa K
Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
Kim I; Rajani R
J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
[TBL] [Abstract][Full Text] [Related]
14. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
Miyauchi A; Fukase M; Tsutsumi M; Fujita T
J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced osteomalacia: long-term follow-up of two patients cured by removal of their tumors.
Sparagana M
J Surg Oncol; 1987 Nov; 36(3):198-205. PubMed ID: 3682838
[TBL] [Abstract][Full Text] [Related]
16. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
[TBL] [Abstract][Full Text] [Related]
17. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.
Nelson AE; Bligh RC; Mirams M; Gill A; Au A; Clarkson A; Jüppner H; Ruff S; Stalley P; Scolyer RA; Robinson BG; Mason RS; Bligh PC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4088-94. PubMed ID: 12970268
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
[TBL] [Abstract][Full Text] [Related]
19. Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.
Ellis MB; Gridley D; Lal S; Nair GR; Feiz-Erfan I
J Neurosurg Pediatr; 2016 May; 17(5):573-7. PubMed ID: 26722864
[TBL] [Abstract][Full Text] [Related]
20. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
Drezner MK; Feinglos MN
J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
